Titre :
  • Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
Auteur : Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) ; Mocroft, Amanda ; Reiss, Peter ; Kirk, Ole ; Mussini, Cristina ; Girardi, Enrico ; Morlat, Philippe ; Stephan, Christoph ; De Wit, Stéphane ; Doerholt, Katja ; Ghosn, Jade ; Bucher, Heiner H.C. ; Lundgren, Jens D ; Chêne, Geneviève ; Miró, José María ; Furrer, Hansjakob
Informations sur la publication : Clinical infectious diseases, 51, 5, (page 611-619)
Statut de publication : Publié, 2010-09
Sujet CREF : Sciences bio-médicales et agricoles
Pathologie maladies infectieuses
Mots-clés MeSH : AIDS-Related Opportunistic Infections -- epidemiology -- immunology -- prevention & control
Adult
Anti-HIV Agents -- administration & dosage
Antifungal Agents -- administration & dosage -- therapeutic use
CD4 Lymphocyte Count
Europe -- epidemiology
Female
HIV Infections -- complications -- drug therapy -- immunology
Humans
Incidence
Male
Middle Aged
Pneumocystis jirovecii
Pneumonia, Pneumocystis -- epidemiology -- immunology -- prevention & control
Risk Factors
Langue :
  • Anglais
Identificateurs : urn:issn:1058-4838 
info:doi/10.1086/655761
info:pmid/20645862